FRANKLIN RESOURCES INC

Position in SNDX — Syndax Pharmaceuticals Inc

CIK 38777 San Mateo, CA

Position in SNDX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$49,982,867

-$242,977 QoQ

Shares Held

2,286,499

+6.3% QoQ

Ownership

2.56%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#12

of 242 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. SNDX ranks #37 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,771,839	$1,728,352,485
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,347,253	$1,662,680,977
3	ASND	Ascendis Pharma A/S	1,862,503	$496,766,798
4	JAZZ	Jazz Pharmaceuticals plc	2,040,250	$491,639,040
5	RVMD	Revolution Medicines, Inc.	1,488,394	$278,746,426
6	INSM	INSMED Inc	2,273,222	$242,370,927
7	LGND	Ligand Pharmaceuticals Inc	752,044	$237,713,585
8	ARGX	Argenx SE	224,930	$208,683,303

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$49,982,867	2,286,499	+6.3%	Shares	Defined	2026-08-13
2026-03-31	$50,225,844	2,150,079	-11.2%	Shares	Defined	2026-05-13
2025-12-31	$50,879,201	2,421,666	+1.3%	Shares	Defined	2026-02-11
2025-09-30	$36,778,779	2,390,561	+1.3%	Shares	Defined	2025-11-13
2025-06-30	$22,098,374	2,359,677	+14.5%	Shares	Defined	2025-08-12
2025-03-31	$25,324,360	2,061,405	+16.7%	Shares	Defined	2025-05-13
2024-12-31	$23,357,875	1,766,859	+0.2%	Shares	Defined	2025-02-12
2024-09-30	$33,943,081	1,763,277	+13.4%	Shares	Defined	2024-11-27
2024-06-30	$31,928,953	1,555,234	+4.0%	Shares	Defined	2024-08-14
2024-03-31	$35,597,778	1,495,705	+10.6%	Shares	Defined	2024-05-13
2023-12-31	$29,236,276	1,352,905	—	Shares	Defined	2024-02-09
No filing history on record for this holder in this stock.